These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 12503474)

  • 1. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
    Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
    Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B; Kjörk E; Brunlöf G
    Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K; Salukhe TV; Coats AJ; Mayet J; Piepoli M; Francis DP
    Int J Cardiol; 2004 Feb; 93(2-3):105-11. PubMed ID: 14975535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
    Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
    Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatment.
    Lainscak M
    Int J Cardiol; 2004 Dec; 97(3):411-6. PubMed ID: 15561327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure.
    Tallaj JA; Franco V; Rayburn BK; Pinderski L; Benza RL; Pamboukian S; Foley B; Bourge RC
    J Heart Lung Transplant; 2005 Dec; 24(12):2196-201. PubMed ID: 16364871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
    Poelzl G; Frick M; Lackner B; Huegel H; Alber HF; Mair J; Herold M; Schwarzacher SP; Pachinger O; Weidinger F
    Int J Cardiol; 2006 Mar; 108(1):48-54. PubMed ID: 16516697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
    Stawicki S; Roik M; Jasik M; Kosior D; Scisło P; Kochanowski J; Dembe K; Steckiewicz R; Karnafel W; Opolski G
    Kardiol Pol; 2004 Nov; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.